Integrating Chlamydia trachomatis Control Services for Males in Female Reproductive Health Programs

Perspectives on Sexual and Reproductive Health

Volumn 35, Issue 5, 2003, Pages 226-228

  McConnell, K John ^a   Packel, Laura ^d   Biggs, M Antonia ^d   Chow, Joan M ^b   Brindis, Claire ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; INFECTION CONTROL; INFECTION PREVENTION; PUBLIC HEALTH SERVICE; REINFECTION; REPRODUCTIVE HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMMUNITY HEALTH CENTERS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; REPRODUCTIVE HEALTH SERVICES; RISK FACTORS; SEX EDUCATION; SEX FACTORS; SEXUAL BEHAVIOR; UNITED STATES;

EID: 0142258909     PISSN: 15386341     EISSN: None     Source Type: Journal    
DOI: 10.1363/3522603     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention (CDC), Sexually Transmitted Disease Surveillance, 2000, Atlanta: CDC, 2001.
2. Petita A, Hart SM and Bailey EM, Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department, Pharmacotherapy, 1999, 19(5):648-654.
3. CDC, 2001, op. cit. (see reference 1).
4. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
5. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
6. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
7. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
8. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
9. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
10. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
11. Whittington WL et al., Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study, Sexually Transmitted Diseases, 2001, 28(2):117-123; Gunn RA, Fitzgerald S and Aral SO, Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: possible 'core' transmitters, Sexually Transmitted Diseases, 2000, 27(6): 343-349; Rietmeijer CA et al., Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening, Sexually Transmitted Diseases, 2002, 29(2):65-72; Hillis SD et al., Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings, Sexually Transmitted Diseases, 1998, 25(1):5-11; Hillis SD et al., Risk factors for recurrent Chlamydia trachomatis infections in women, American Journal of Obstetrics and Gynecology, 1994,170(3):801-806; Blythe MJ et al., Recurrent genitourinary chlamydial infections in sexually active female adolescents, Journal of Pediatrics, 1992, 121(3):487-493; Burstein GR et al., Incident Chlamydia trachomatis infections among inner-city adolescent females, Journal of the American Medical Association, 1998, 280(6):521-526; and Oh MK et al., Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study, Journal of Adolescent Health, 1996, 18(4): 270-275.
12. Rietmeijer CA et al., 2002, op. cit. (see reference 4).
13. Gunn RA, Fitzgerald S and Aral SO, 2000, op. cit. (see reference 4).
14. Hillis SD et al., Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease, American Journal of Obstetrics and Gynecology, 1997, 176(1):103-107.
15. Cowan FM, French R and Johnson AM, The role and effectiveness of partner notification in STD control: a review, Genitourinary Medicine, 1996, 72(4):247-252; Fitzgerald M and Bell G, Measuring the effectiveness of contact tracing, International Journal of STD and AIDS, 1998, 9(11):645-646; and Oxman AD et al., Partner notification for sexually transmitted diseases: an overview of the evidence, Canadian Journal of Public Health, 1994, 85(Suppl. 1):S41-47.
16. Cowan FM, French R and Johnson AM, The role and effectiveness of partner notification in STD control: a review, Genitourinary Medicine, 1996, 72(4):247-252; Fitzgerald M and Bell G, Measuring the effectiveness of contact tracing, International Journal of STD and AIDS, 1998, 9(11):645-646; and Oxman AD et al., Partner notification for sexually transmitted diseases: an overview of the evidence, Canadian Journal of Public Health, 1994, 85(Suppl. 1):S41-47.
17. Cowan FM, French R and Johnson AM, The role and effectiveness of partner notification in STD control: a review, Genitourinary Medicine, 1996, 72(4):247-252; Fitzgerald M and Bell G, Measuring the effectiveness of contact tracing, International Journal of STD and AIDS, 1998, 9(11):645-646; and Oxman AD et al., Partner notification for sexually transmitted diseases: an overview of the evidence, Canadian Journal of Public Health, 1994, 85(Suppl. 1):S41-47.
18. Schillinger JA et al., Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial, Sexually Transmitted Diseases, 2003, 30(1):49-56.
19. Macke BA, Hennessy MH and McFarlane M, Predictors of time spent on partner notification in four U.S. sites, Sexually Transmitted Infections, 2000, 76(5):371-374.
20. Macke BA and Maher JE, Partner notification in the United States: an evidence-based review, American Journal of Preventive Medicine, 1999, 17(3):230-242.
21. St. Lawrence JS et al., STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of U.S. physicians, American Journal of Public Health, 2002, 92(11):1784-1788.
22. Gorbach PM et al., To notify or not to notify: STD patients' perspectives of partner notification in Seattle, Sexually Transmitted Diseases, 2000, 27(4):193-200.
23. Hillis SD et al., 1997, op. cit. (see reference 7).
24. Ginocchio RH et al., The clinical and economic consequences of screening young men for genital chlamydial infection, Sexually Transmitted Diseases, 2003, 30(2):99-106; Mehta SD et al., Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients, Sexually Transmitted Diseases, 2002, 29(2):83-91; and Randolph AG and Washington AE, Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis, American Journal of Public Health, 1990, 80(5):545-550.
25. Ginocchio RH et al., The clinical and economic consequences of screening young men for genital chlamydial infection, Sexually Transmitted Diseases, 2003, 30(2):99-106; Mehta SD et al., Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients, Sexually Transmitted Diseases, 2002, 29(2):83-91; and Randolph AG and Washington AE, Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis, American Journal of Public Health, 1990, 80(5):545-550.
26. Ginocchio RH et al., The clinical and economic consequences of screening young men for genital chlamydial infection, Sexually Transmitted Diseases, 2003, 30(2):99-106; Mehta SD et al., Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients, Sexually Transmitted Diseases, 2002, 29(2):83-91; and Randolph AG and Washington AE, Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis, American Journal of Public Health, 1990, 80(5):545-550.
27. Genc M, Ruusuvaara L and Mardh PA, An economic evaluation of screening for Chlamydia trachomatis in adolescent males, Journal of the American Medical Association, 1993, 270(17):2057-2064; and Gift T et al., A cost effectiveness analysis of screening asymptomatic men for Chlamydia trachomatis to prevent PID in women, Atlanta: CDC, 2001.
28. Genc M, Ruusuvaara L and Mardh PA, An economic evaluation of screening for Chlamydia trachomatis in adolescent males, Journal of the American Medical Association, 1993, 270(17):2057-2064; and Gift T et al., A cost effectiveness analysis of screening asymptomatic men for Chlamydia trachomatis to prevent PID in women, Atlanta: CDC, 2001.
29. The Alan Guttmacher Institute (AGI), In Their Own Right: Addressing the Sexual and Reproductive Health Needs of American Men, New York: AGI, 2002.
30. Center for Reproductive Health Research and Policy, University of California at San Francisco, Family PACT program report FY 99/00: a report to the State of California, Department of Health Services, Office of Family Planning, San Francisco: Center for Reproductive Health Research and Policy, 2001.